FANJ
CRL icon

Financial Architects (New Jersey)’s Charles River Laboratories CRL Stock Holding History

Financial Architects (New Jersey)’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,000
Closed -$135K – 1359
2018
Q3 		$135K Buy
+1,000
New +$123K 0.02% 389

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Financial Architects (New Jersey)'s CRL Position: Q3 2017 in Review

Financial Architects (New Jersey) sold out of Charles River Laboratories (CRL) in Q3 2017, closing a stake of 40 shares — an estimated $4K sold.

Financial Architects (New Jersey) first reported a position in CRL in Q1 2017 and held it in 2 quarters. The position peaked at $4K in Q2 2017. 336 funds tracked by Wall St. Rank hold CRL as of Q3 2017.

  • Financial Architects (New Jersey) reported no remaining Charles River Laboratories position as of Q3 2017 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 40 Charles River Laboratories shares in Q3 2017, an estimated $4K.
  • Financial Architects (New Jersey) first reported a position in Charles River Laboratories in Q1 2017 and held it in 2 quarters.
  • Financial Architects (New Jersey)'s Charles River Laboratories position peaked at $4K in Q2 2017.
  • 336 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2017.

Based on Financial Architects (New Jersey)'s 13F filing for Q3 2017, filed 23 Oct 2017.